- Location
drug delivery technology
"-
IntelGenx Has Received a Notice of Allowance From The US Patent and Trademark Office
Feb 28, 2014IntelGenx, a Canadian drug delivery company focusing on oral drug delivery, has announced that it has received a notice of allowance from the US Patent and Trademark Office for its Patent Application Serial No. 11/647,033 entitled ...
Tags: IntelGenx, Proprietary Technology
-
Rainbow Coral and Its Joint Venture Partner Have Reached a Major New Milestone
Dec 16, 2013Rainbow Coral and its joint venture partner, Therakine, have reached a major new milestone in the development of a revolutionary new drug delivery technology. The companies reached terms to initiate Phase II of research and analysis on a ...
Tags: RBCC, Drug Delivery Development
-
CDRD Ventures Has Announced The Launch of a New Spin-off Company
Dec 5, 2013CDRD Ventures, the commercialization vehicle of The Centre for Drug Research and Development (CDRD), has announced the launch of a new spin-off company, Sitka Biopharma is a biotechnology company developing a new bladder cancer treatment. ...
-
Impax Has Started Shipment of Generic Solaraze
Nov 22, 2013US-based specialty pharmaceutical firm Impax Laboratories (Impax) has started shipment of generic Solaraze (diclofenac sodium gel, 3%), a first-to-file product, through its generics division Global Pharmaceuticals. In order to ...
-
Zogenix Has Announced That The US FDA Has Approved Zohydro ER Extended-Release Capsules.
Oct 30, 2013Pharmaceutical companyc Food and Drug Administration (FDA) has approved Zohydro ER (hydrocodone bitartrate) extended-release capsules. Zohydro ER is an opioid agonist, extended-release oral formulation of hydrocodone without ...
-
Antares Pharma Has Received a US Patent,Entitled 'Prefilled Syringe Jet Injector'
Oct 29, 2013Antares Pharma, a provider of self-injection drug delivery technology, has received a US Patent, entitled 'Prefilled Syringe Jet Injector', which will help in protecting its auto injector technology and product pipeline including the VIBEX ...
-
Collegium Pharmaceutical Has Announced That a Patent Has Been Issued by USPTO
Oct 21, 2013Collegium Pharmaceutical, a specialty pharmaceutical company, has announced that a patent has been issued by the US Patent and Trademark Office (USPTO) covering its Oxycodone DETERx formulation. Additionally, an application has been ...
-
Sigma-Tau PharmaSource Has Entered Into a Manufacturing Services Agreement with Aradigm
Sep 18, 2013Biopharmaceutical contract manufacturer Sigma-Tau PharmaSource has entered into a manufacturing services agreement with Aradigm, a specialty pharmaceutical firm focused on the development and commercialization of drugs delivered by ...
-
InSite Vision's DuraSite 2 Next-Generation Enhanced Drug Delivery System Got Patent
Aug 20, 2013The US Patent and Trademark Office (USPTO) has granted an US patent to the InSite Vision’s DuraSite 2 next-generation enhanced drug delivery system, which will be valid up to 2029 for internal pipeline and partnering. Offering a ...
Tags: Drug Delivery System
-
Aegis Therapeutics LLC Obtained New Zealand Patent Providing Coverage
Aug 16, 2013Aegis Therapeutics LLC, a US-based drug delivery technology company, has obtained New Zealand patent providing coverage through December 2029 for fast acting formulations of triptans. The New Zealand patent is the third patent awarded to ...
Tags: Aegis, Fast Acting Formulations
-
Trimel Biopharma SRL Has Partnered with a Privately-Held European Company
Mar 21, 2013Trimel Biopharma SRL, a wholly-owned subsidiary of Trimel Pharmaceuticals, has partnered with a privately-held European company to develop single dose and fixed dose combinations of a portfolio of active pharmaceutical ingredients for the ...
Tags: respiratory therapies, Trimel, Biopharma
-
USPTO Has Granted Notice of Allowance to Collegium Pharmaceutical's Patent Applicat
Feb 19, 2013The US Patent and Trademark Office (USPTO) has granted notice of allowance (NOA) to Collegium Pharmaceutical's patent application NO.12/823,628 covering a tamper-resistant, extended-release opioid product. The patent entitled, ...
Tags: USPTO, NOA, Collegium Opioid Product
-
TissueGen®'s Patented Extrusion Technology Enables Absorbable Fibers to Be Loaded
Feb 16, 2013TissueGen® Inc., developer of a cutting-edge absorbable polymer technology for implantable drug delivery across a wide variety of therapeutic applications, today announced that its patented extrusion technology enables absorbable fibers ...
Tags: cutting-edge absorbable polymer technology, implantable drug delivery
-
OncoSec Medical Has Obtained CE Certification to Treat Solid Tumor Cancers
Dec 18, 2012OncoSec Medical has obtained CE certification for its proprietary gene and drug delivery technology, designed to treat solid tumor cancers. The assessment and certification process was supervised by SGS Group, a provider of inspection, ...
Tags: OncoSec, CE certification, proprietary gene, drug delivery technology
-
USPTO Has Granted a Noa to Sanovas' Nested Balloon Catheter for Localized Drug Delivery
Dec 18, 2012The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Sanovas' minimally invasive nested balloon catheter for localized drug delivery. The patent will protect an integral part of the company's NanoVas ...
Tags: USPTO, NOA, minimally invasive nested balloon catheter, medical product
